CHRISTEL HAYES: Open Payments
NPI 1649651043 · FLORENCE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 15 payments from 13 companies in 2025. Trend: 2023 $463 · 2024 $766 · 2025 $351
Food & beverage: $308Education: $43
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 1 | $43 |
| Janssen Biotech, Inc. | 2 | $43 |
| PFIZER INC. | 2 | $39 |
| BeOne Medicines USA, Inc. | 1 | $34 |
| Merck Sharp & Dohme LLC | 1 | $33 |
| Aveo Pharmaceuticals, Inc. | 1 | $27 |
| GENZYME CORPORATION | 1 | $25 |
| Adaptive Biotechnologies Corporation | 1 | $21 |
| Celgene Corporation | 1 | $20 |
| SpringWorks Therapeutics, Inc. | 1 | $19 |
Products named: ENHERTU, BRUKINSA, KEYTRUDA, FOTIVDA, ALTUVIIIO, TECVAYLI, XTANDI, clonoSEQ.
Industry payments across SC — which companies pay providers there.
